Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 21, 2016; 22(3): 1131-1138
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1131
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1131
Figure 1 Randomization, treatment schemes and outcomes of the INT-0116 trial by Macdonald et al.
LV: Leucovorin; 5-FU: 5-fluorouracil; RT: Radiotherapy; CRT: Chemoradiotherapy.
Figure 2 Long-term outcomes after 15 years follow up of the Dutch randomized trial by Bonenkamp et al D1 vs D2 node dissection.
Figure 3 Randomization, treatment schemes and outcomes of the Chinese trial by Zhu et al.
LV: Leucovorin; 5-FU: 5-fluorouracil; IMRT: Intensity modulated radiotherapy; C: Chemotherapy.
- Citation: Agolli L, Maurizi Enrici R, Osti MF. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients? World J Gastroenterol 2016; 22(3): 1131-1138
- URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1131.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i3.1131